ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,735.27
      1.46%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      09/19/20194:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/18/20194:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/17/20195:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/17/20195:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/17/20195:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/17/20195:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/10/20194:54PMDow Jones NewsLexicon Pharmaceuticals Says It Terminated Sanofi AllianceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/10/20194:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/10/20194:01PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Ann...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/10/20194:01PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With SanofiNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/30/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals To Present At Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/20/20195:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/08/20195:23PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Publication of Positive Data for Zynquista™ (Sotagliflozin) on Cardiorenal Clinical Bioma...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20194:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20194:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20194:54PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/31/20197:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/31/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides a Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/201912:59PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Date Change for Second Quarter 2019 Financial Results Conference Call and Webcast to July 3...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/29/20196:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/26/20197:09PMDow Jones NewsSanofi Terminates Partnership With Lexicon to Develop Antidiabetic Drug -- UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/26/20196:49PMDow Jones NewsSanofi Terminates Partnership to Develop Antidiabetic Drug With LexiconNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/26/20196:02PMDow Jones NewsLexicon Pharma Shares Plunge 48% After Sanofi Says It Wants to End AllianceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/26/20195:15PMGlobeNewswire Inc.Lexicon Pharmaceuticals Provides Preliminary Update for Zynquista™ (Sotagliflozin) Type 2 Diabetes Phase 3 ProgramNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/25/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on August 1, 2019NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/04/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present New Clinical Data at 79th American Diabetes Association Scientific SessionsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/08/20197:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/01/20194:20PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX